tiprankstipranks
Trending News
More News >
Algernon Pharmaceuticals (AGNPF)
OTHER OTC:AGNPF
US Market

Algernon Pharmaceuticals (AGNPF) Income Statement

Compare
71 Followers

Algernon Pharmaceuticals Income Statement

Last quarter (Q1 2025), Algernon Pharmaceuticals's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q1, Algernon Pharmaceuticals's net income was C$-381.06K. See Algernon Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Sep 24Sep 23Sep 22Sep 21Sep 20
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ -26.56KC$ -50.40KC$ -34.94KC$ 0.00C$ 0.00
Operating Expenses
C$ 2.39MC$ 5.24MC$ 6.06MC$ 8.05MC$ 8.68M
Depreciation and Amortization
C$ 26.56KC$ 50.40KC$ 34.94KC$ 7.88MC$ 27.00K
EBITDA
C$ -476.42KC$ -4.98MC$ -6.02MC$ 0.00C$ -8.54M
Operating Income
C$ -2.41MC$ -5.02MC$ -6.06MC$ -8.05MC$ -8.76M
Other Income/Expenses
C$ 1.91MC$ -1.76MC$ 63.27KC$ 2.11MC$ 858.46K
Pretax Income
C$ -502.98KC$ -6.78MC$ -6.05MC$ -7.73MC$ -8.54M
Net Income
C$ -502.98KC$ -6.78MC$ -6.05MC$ -7.72MC$ -8.42M
Per Share Metrics
Basic EPS
C$ -0.03C$ -0.45C$ -0.73C$ -1.04C$ -2.00
Diluted EPS
C$ -0.03C$ -0.45C$ -0.73C$ -1.04C$ -2.00
Weighted Average Shares Outstanding
20.05M 15.15M 8.30M 7.44M 4.21M
Weighted Average Shares Outstanding (Diluted)
20.05M 15.15M 8.30M 7.44M 4.21M
Currency in CAD

Algernon Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis